Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-02-24 @ 2:07 PM
Study NCT ID:
NCT00003532
Status:
TERMINATED
Last Update Posted:
2017-12-12
First Post:
1999-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Sponsor:
Burzynski Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000066579
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None